(Q35644204)

English

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

scientific article published on 17 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women (English)

1 reference

Europe PubMed Central

9 August 2017

8

object named as

D L Kendler

1 reference

Europe PubMed Central

9 August 2017

author name string

N Freemantle

1

1 reference

Europe PubMed Central

9 August 2017

S Satram-Hoang

2

1 reference

Europe PubMed Central

9 August 2017

E-T Tang

3

1 reference

Europe PubMed Central

9 August 2017

P Kaur

4

1 reference

Europe PubMed Central

9 August 2017

D Macarios

5

1 reference

Europe PubMed Central

9 August 2017

S Siddhanti

6

1 reference

Europe PubMed Central

9 August 2017

J Borenstein

7

1 reference

Europe PubMed Central

9 August 2017

DAPS Investigators

9

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

17 September 2011

1 reference

Europe PubMed Central

9 August 2017

Osteoporosis International

1 reference

Europe PubMed Central

9 August 2017

23

1 reference

Europe PubMed Central

9 August 2017

1

1 reference

Europe PubMed Central

9 August 2017

317-326

1 reference

Europe PubMed Central

9 August 2017

https://scigraph.springernature.com/pub.10.1007/s00198-011-1780-1

0 references

Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Adherence, patient preference and dosing frequency: understanding the relationship

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Bone safety of long-term bisphosphonate treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

12 July 2018

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

Fracture outcomes related to persistence and compliance with oral bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3249211

25 September 2018

Potential clinical and economic impact of nonadherence with osteoporosis medications

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1780-1

21 January 2018

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1780-1

21 January 2018

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1780-1

21 January 2018

Incorporating adherence into health economic modelling of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21927922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing adherence and persistence across 6 chronic medication classes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21927922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21927922

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-011-1780-1

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35644204&oldid=1582254951"